 | • レポートコード：MRC2012B0572 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、内部神経調節の世界市場を広く調査・分析し、今後の市場展望をまとめております。内部神経調節の種類別市場規模（脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激、その他）、用途別市場規模（疾病治療、研究・開発）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、NeuroPace、LivaNova、Boston Scientific Corporation、NeuroSigma、Abbott、BioControl Medical、Nevro Corporation、Synapse Biomedical、Neuronetics ・地域別グローバル市場分析 2015年-2020年 ・内部神経調節の北米市場（アメリカ、カナダ、メキシコ） ・内部神経調節のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・内部神経調節のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・内部神経調節の南米市場（ブラジル、アルゼンチン） ・内部神経調節の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激、その他 ・用途別分析：疾病治療、研究・開発 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Internal Neuromodulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Internal Neuromodulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Internal Neuromodulation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Internal Neuromodulation market has been segmented into:
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
Others
By Application, Internal Neuromodulation has been segmented into:
Disease Therapy
Research and Development
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Internal Neuromodulation market presented in the report. This section sheds light on the sales growth of different regional and country-level Internal Neuromodulation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Internal Neuromodulation market.
The report offers in-depth assessment of the growth and other aspects of the Internal Neuromodulation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Internal Neuromodulation Market Share Analysis
Internal Neuromodulation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Internal Neuromodulation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Internal Neuromodulation sales, revenue and market share for each player covered in this report.
The major players covered in Internal Neuromodulation are:
Medtronic
NeuroPace
LivaNova
Boston Scientific Corporation
NeuroSigma
Abbott
BioControl Medical
Nevro Corporation
Synapse Biomedical
Neuronetics
Among other players domestic and global, Internal Neuromodulation market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Internal Neuromodulation Market Overview
1.1 Product Overview and Scope of Internal Neuromodulation
1.2 Classification of Internal Neuromodulation by Type
1.2.1 Global Internal Neuromodulation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Internal Neuromodulation Revenue Market Share by Type in 2019
1.2.3 Spinal Cord Stimulation
1.2.4 Deep Brain Stimulation
1.2.5 Vagus Nerve Stimulation
1.2.6 Sacral Nerve Stimulation
1.2.7 Gastric Electrical Stimulation
1.2.8 Others
1.3 Global Internal Neuromodulation Market by Application
1.3.1 Overview: Global Internal Neuromodulation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Disease Therapy
1.3.3 Research and Development
1.4 Global Internal Neuromodulation Market by Regions
1.4.1 Global Internal Neuromodulation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Internal Neuromodulation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Internal Neuromodulation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Internal Neuromodulation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Internal Neuromodulation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Internal Neuromodulation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Internal Neuromodulation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.2 NeuroPace
2.2.1 NeuroPace Details
2.2.2 NeuroPace Major Business
2.2.3 NeuroPace SWOT Analysis
2.2.4 NeuroPace Product and Services
2.2.5 NeuroPace Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.3 LivaNova
2.3.1 LivaNova Details
2.3.2 LivaNova Major Business
2.3.3 LivaNova SWOT Analysis
2.3.4 LivaNova Product and Services
2.3.5 LivaNova Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation SWOT Analysis
2.4.4 Boston Scientific Corporation Product and Services
2.4.5 Boston Scientific Corporation Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.5 NeuroSigma
2.5.1 NeuroSigma Details
2.5.2 NeuroSigma Major Business
2.5.3 NeuroSigma SWOT Analysis
2.5.4 NeuroSigma Product and Services
2.5.5 NeuroSigma Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Product and Services
2.6.4 Abbott Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioControl Medical
2.7.1 BioControl Medical Details
2.7.2 BioControl Medical Major Business
2.7.3 BioControl Medical Product and Services
2.7.4 BioControl Medical Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nevro Corporation
2.8.1 Nevro Corporation Details
2.8.2 Nevro Corporation Major Business
2.8.3 Nevro Corporation Product and Services
2.8.4 Nevro Corporation Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.9 Synapse Biomedical
2.9.1 Synapse Biomedical Details
2.9.2 Synapse Biomedical Major Business
2.9.3 Synapse Biomedical Product and Services
2.9.4 Synapse Biomedical Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Neuronetics
2.10.1 Neuronetics Details
2.10.2 Neuronetics Major Business
2.10.3 Neuronetics Product and Services
2.10.4 Neuronetics Internal Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Internal Neuromodulation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Internal Neuromodulation Players Market Share
3.2.2 Top 10 Internal Neuromodulation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Internal Neuromodulation Revenue and Market Share by Regions
4.2 North America Internal Neuromodulation Revenue and Growth Rate (2015-2020)
4.3 Europe Internal Neuromodulation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Internal Neuromodulation Revenue and Growth Rate (2015-2020)
4.5 South America Internal Neuromodulation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Internal Neuromodulation Revenue and Growth Rate (2015-2020)
5 North America Internal Neuromodulation Revenue by Countries
5.1 North America Internal Neuromodulation Revenue by Countries (2015-2020)
5.2 USA Internal Neuromodulation Revenue and Growth Rate (2015-2020)
5.3 Canada Internal Neuromodulation Revenue and Growth Rate (2015-2020)
5.4 Mexico Internal Neuromodulation Revenue and Growth Rate (2015-2020)
6 Europe Internal Neuromodulation Revenue by Countries
6.1 Europe Internal Neuromodulation Revenue by Countries (2015-2020)
6.2 Germany Internal Neuromodulation Revenue and Growth Rate (2015-2020)
6.3 UK Internal Neuromodulation Revenue and Growth Rate (2015-2020)
6.4 France Internal Neuromodulation Revenue and Growth Rate (2015-2020)
6.5 Russia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
6.6 Italy Internal Neuromodulation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Internal Neuromodulation Revenue by Countries
7.1 Asia-Pacific Internal Neuromodulation Revenue by Countries (2015-2020)
7.2 China Internal Neuromodulation Revenue and Growth Rate (2015-2020)
7.3 Japan Internal Neuromodulation Revenue and Growth Rate (2015-2020)
7.4 Korea Internal Neuromodulation Revenue and Growth Rate (2015-2020)
7.5 India Internal Neuromodulation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
8 South America Internal Neuromodulation Revenue by Countries
8.1 South America Internal Neuromodulation Revenue by Countries (2015-2020)
8.2 Brazil Internal Neuromodulation Revenue and Growth Rate (2015-2020)
8.3 Argentina Internal Neuromodulation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Internal Neuromodulation by Countries
9.1 Middle East & Africa Internal Neuromodulation Revenue by Countries (2015-2020)
9.2 Saudi Arabia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
9.3 UAE Internal Neuromodulation Revenue and Growth Rate (2015-2020)
9.4 Egypt Internal Neuromodulation Revenue and Growth Rate (2015-2020)
9.5 South Africa Internal Neuromodulation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Internal Neuromodulation Revenue and Market Share by Type (2015-2020)
10.2 Global Internal Neuromodulation Market Forecast by Type (2019-2024)
10.3 Spinal Cord Stimulation Revenue Growth Rate (2015-2025)
10.4 Deep Brain Stimulation Revenue Growth Rate (2015-2025)
10.5 Vagus Nerve Stimulation Revenue Growth Rate (2015-2025)
10.6 Sacral Nerve Stimulation Revenue Growth Rate (2015-2025)
10.7 Gastric Electrical Stimulation Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Internal Neuromodulation Market Segment by Application
11.1 Global Internal Neuromodulation Revenue Market Share by Application (2015-2020)
11.2 Internal Neuromodulation Market Forecast by Application (2019-2024)
11.3 Disease Therapy Revenue Growth (2015-2020)
11.4 Research and Development Revenue Growth (2015-2020)
12 Global Internal Neuromodulation Market Size Forecast (2021-2025)
12.1 Global Internal Neuromodulation Market Size Forecast (2021-2025)
12.2 Global Internal Neuromodulation Market Forecast by Regions (2021-2025)
12.3 North America Internal Neuromodulation Revenue Market Forecast (2021-2025)
12.4 Europe Internal Neuromodulation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Internal Neuromodulation Revenue Market Forecast (2021-2025)
12.6 South America Internal Neuromodulation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Internal Neuromodulation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Internal Neuromodulation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Internal Neuromodulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Internal Neuromodulation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Internal Neuromodulation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Internal Neuromodulation Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Medtronic Corporate Information, Location and Competitors
Table 7. Medtronic Internal Neuromodulation Major Business
Table 8. Medtronic Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 9. Medtronic SWOT Analysis
Table 10. Medtronic Internal Neuromodulation Product and Solutions
Table 11. Medtronic Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. NeuroPace Corporate Information, Location and Competitors
Table 13. NeuroPace Internal Neuromodulation Major Business
Table 14. NeuroPace Internal Neuromodulation Total Revenue (USD Million) (2018-2019)
Table 15. NeuroPace SWOT Analysis
Table 16. NeuroPace Internal Neuromodulation Product and Solutions
Table 17. NeuroPace Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. LivaNova Corporate Information, Location and Competitors
Table 19. LivaNova Internal Neuromodulation Major Business
Table 20. LivaNova Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 21. LivaNova SWOT Analysis
Table 22. LivaNova Internal Neuromodulation Product and Solutions
Table 23. LivaNova Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Boston Scientific Corporation Corporate Information, Location and Competitors
Table 25. Boston Scientific Corporation Internal Neuromodulation Major Business
Table 26. Boston Scientific Corporation Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 27. Boston Scientific Corporation SWOT Analysis
Table 28. Boston Scientific Corporation Internal Neuromodulation Product and Solutions
Table 29. Boston Scientific Corporation Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. NeuroSigma Corporate Information, Location and Competitors
Table 31. NeuroSigma Internal Neuromodulation Major Business
Table 32. NeuroSigma Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 33. NeuroSigma SWOT Analysis
Table 34. NeuroSigma Internal Neuromodulation Product and Solutions
Table 35. NeuroSigma Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Abbott Corporate Information, Location and Competitors
Table 37. Abbott Internal Neuromodulation Major Business
Table 38. Abbott Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 39. Abbott SWOT Analysis
Table 40. Abbott Internal Neuromodulation Product and Solutions
Table 41. Abbott Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. BioControl Medical Corporate Information, Location and Competitors
Table 43. BioControl Medical Internal Neuromodulation Major Business
Table 44. BioControl Medical Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 45. BioControl Medical SWOT Analysis
Table 46. BioControl Medical Internal Neuromodulation Product and Solutions
Table 47. BioControl Medical Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Nevro Corporation Corporate Information, Location and Competitors
Table 49. Nevro Corporation Internal Neuromodulation Major Business
Table 50. Nevro Corporation Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 51. Nevro Corporation SWOT Analysis
Table 52. Nevro Corporation Internal Neuromodulation Product and Solutions
Table 53. Nevro Corporation Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Synapse Biomedical Corporate Information, Location and Competitors
Table 55. Synapse Biomedical Internal Neuromodulation Major Business
Table 56. Synapse Biomedical Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 57. Synapse Biomedical SWOT Analysis
Table 58. Synapse Biomedical Internal Neuromodulation Product and Solutions
Table 59. Synapse Biomedical Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Neuronetics Corporate Information, Location and Competitors
Table 61. Neuronetics Internal Neuromodulation Major Business
Table 62. Neuronetics Internal Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 63. Neuronetics SWOT Analysis
Table 64. Neuronetics Internal Neuromodulation Product and Solutions
Table 65. Neuronetics Internal Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Internal Neuromodulation Revenue (Million USD) by Players (2015-2020)
Table 67. Global Internal Neuromodulation Revenue Share by Players (2015-2020)
Table 68. Global Internal Neuromodulation Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Internal Neuromodulation Revenue Market Share by Regions (2015-2020)
Table 70. North America Internal Neuromodulation Revenue by Countries (2015-2020)
Table 71. North America Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 72. Europe Internal Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Internal Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Internal Neuromodulation Revenue by Countries (2015-2020)
Table 75. South America Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Internal Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 78. Global Internal Neuromodulation Revenue (Million USD) by Type (2015-2020)
Table 79. Global Internal Neuromodulation Revenue Share by Type (2015-2020)
Table 80. Global Internal Neuromodulation Revenue Forecast by Type (2021-2025)
Table 81. Global Internal Neuromodulation Revenue by Application (2015-2020)
Table 82. Global Internal Neuromodulation Revenue Share by Application (2015-2020)
Table 83. Global Internal Neuromodulation Revenue Forecast by Application (2021-2025)
Table 84. Global Internal Neuromodulation Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Internal Neuromodulation Picture
Figure 2. Global Internal Neuromodulation Revenue Market Share by Type in 2019
Figure 3. Spinal Cord Stimulation Picture
Figure 4. Deep Brain Stimulation Picture
Figure 5. Vagus Nerve Stimulation Picture
Figure 6. Sacral Nerve Stimulation Picture
Figure 7. Gastric Electrical Stimulation Picture
Figure 8. Others Picture
Figure 9. Internal Neuromodulation Revenue Market Share by Application in 2019
Figure 10. Disease Therapy Picture
Figure 11. Research and Development Picture
Figure 12. Global Internal Neuromodulation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Internal Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Internal Neuromodulation Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Internal Neuromodulation Revenue Market Share in 2019
Figure 21. Global Top 10 Players Internal Neuromodulation Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Internal Neuromodulation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Internal Neuromodulation Revenue Market Share by Regions (2015-2020)
Figure 25. Global Internal Neuromodulation Revenue Market Share by Regions in 2018
Figure 26. North America Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 27. Europe Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 29. South America Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 31. North America Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 32. North America Internal Neuromodulation Revenue Market Share by Countries in 2019
Figure 33. USA Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 34. Canada Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 36. Europe Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Internal Neuromodulation Revenue Market Share by Countries in 2019
Figure 38. Germany Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 39. UK Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 40. France Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 41. Russia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 42. Italy Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Internal Neuromodulation Revenue Market Share by Countries in 2019
Figure 45. China Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 46. Japan Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 47. Korea Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 48. India Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 50. South America Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 51. South America Internal Neuromodulation Revenue Market Share by Countries in 2019
Figure 52. Brazil Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Internal Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Internal Neuromodulation Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 57. UAE Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Internal Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 60. Global Internal Neuromodulation Revenue Share by Type (2015-2020)
Figure 61. Global Internal Neuromodulation Revenue Share by Type in 2019
Figure 62. Global Internal Neuromodulation Market Share Forecast by Type (2021-2025)
Figure 63. Global Spinal Cord Stimulation Revenue Growth Rate (2015-2020)
Figure 64. Global Deep Brain Stimulation Revenue Growth Rate (2015-2020)
Figure 65. Global Vagus Nerve Stimulation Revenue Growth Rate (2015-2020)
Figure 66. Global Sacral Nerve Stimulation Revenue Growth Rate (2015-2020)
Figure 67. Global Gastric Electrical Stimulation Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Internal Neuromodulation Revenue Share by Application (2015-2020)
Figure 70. Global Internal Neuromodulation Revenue Share by Application in 2019
Figure 71. Global Internal Neuromodulation Market Share Forecast by Application (2021-2025)
Figure 72. Global Disease Therapy Revenue Growth Rate (2015-2020)
Figure 73. Global Research and Development Revenue Growth Rate (2015-2020)
Figure 74. Global Internal Neuromodulation Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Internal Neuromodulation Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Internal Neuromodulation Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Internal Neuromodulation Revenue Market Forecast (2021-2025)
Figure 78. Europe Internal Neuromodulation Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Internal Neuromodulation Revenue Market Forecast (2021-2025)
Figure 80. South America Internal Neuromodulation Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Internal Neuromodulation Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
内部神経調節の世界市場（～2026年） Market Analysis and Insights: Global Internal Neuromodulation Market The global Internal Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 外部神経調節の世界市場（～2026年） Market Analysis and Insights: Global External Neuromodulation Market The global External Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global External Neuromodulation Scope and Market Size External Neuromodu…
- 脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…
- 神経調節の世界市場（～2026年） Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incid…
- 仙骨神経刺激の世界市場（～2026年） Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product s…